Oct. 15, 2015
Startup Gets $52 Million Investment to Develop Drug Treatment for Hearing Loss
BOSTON, MASSACHUSETTS – Third Rock Ventures, a biotechnology-focused venture capital firm located in Boston, announced the launch of a new startup company with the sole purpose of treating hearing loss. The new company, Decibel Therapeutics, raised $52 million dollars in Series A funding for its launch, with investment from Third Rock Ventures and SR One—the venture capital arm of pharmaceutical giant GlaxoSmithKline.{{1}}[[1]]GlaxoSmithKline is the world’s sixth-largest